Journal of Comparative Effectiveness Research

Papers
(The H4-Index of Journal of Comparative Effectiveness Research is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis49
Journal of Comparative Effectiveness Research : 2022 year in review46
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy38
Access in all areas? A round-up of developments in market access and health technology assessment: part 1036
Engaging veterans in the research process: a practical guide31
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary30
Economic burden of sickle cell disease in the United States: a retrospective analysis of a commercial insurance database27
Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis26
Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis26
Acute effects of resistance exercise with blood flow restriction on cardiovascular response: a meta-analysis25
Ataluren for the treatment of people living with nonsense mutation Duchenne muscular dystrophy: a plain language summary of Study 04125
Postoperative outcomes and anesthesia type in total knee arthroplasty in patients with obstructive sleep apnea22
Corrigendum22
Effectiveness and safety of asfotase alfa for people with hypophosphatasia: a plain language summary of three studies21
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis20
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 2018
Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims17
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study17
Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases17
0.10559701919556